Wolfgang Marguerre
Chief Executive Officer bei Octapharma AG
Vermögen: 224 Mio $ am 31.03.2024
Profil
Wolfgang Hubert Marguerre is the founder of Octapharma Nordic AB, founded in 1983, where he holds the title of Chairman.
He is also the founder of Octapharma GmbH, founded in 1983, where he holds the title of Chairman & Chief Executive Officer.
Currently, Mr. Marguerre holds the position of Chairman-Management Board at Octapharma AG, Chairman at Octapharma USA, Inc., Director at Octapharma AB, and Director at Octapharma Ltd.
In the past, he served as the Director General at Octapharma SAS.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.08.2023 | 4 714 675 ( 63,83% ) | 224 Mio $ | 31.03.2024 |
Aktive Positionen von Wolfgang Marguerre
| Unternehmen | Position | Beginn |
|---|---|---|
Octapharma AG
 Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | Chief Executive Officer | - |
Octapharma AB
 Octapharma AB Pharmaceuticals: MajorHealth Technology Octapharma AB manufactures and distributes pharmaceutical products. Its products used for treatment in coagulation disorders, immune disease, and intensive care and emergency medicine. The company operates as a subsidiary of Octapharma AG. Octapharma was founded in 1997 and is located in Stockholm, Sweden. | Director/Board Member | 06.06.2011 |
Octapharma Gmbh
 Octapharma Gmbh Pharmaceuticals: MajorHealth Technology Octapharma GmbH specializes in the development and manufacture of preparations from human plasma. It focuses on virus-inactivated drugs for the treatment of diseases in the fields of immunology, hemophilia and Iten sivmedizin. The company was founded in 1983 and is headquartered in Langenfeld, Germany. | Chief Executive Officer | 01.01.1983 |
Octapharma Ltd.
 Octapharma Ltd. BiotechnologyHealth Technology Part of Octapharma AG, Octapharma Ltd. is a British company that manufactures human protein products. The private company is based in Manchester, UK. Octapharma was founded in 1983. | Director/Board Member | - |
Octapharma USA, Inc.
 Octapharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Octapharma AG, Octapharma USA, Inc. develops and manufactures medicines for hematology, immunotherapy, and critical care patients. The private company is based in Paramus, NJ. | Chairman | - |
Octapharma Nordic AB
 Octapharma Nordic AB Pharmaceuticals: MajorHealth Technology Octapharma Nordic AB specializes in the production and distribution of plasma derivative. Its products are used for the treatment in coagulation disorders, immune disease and intensive care and emergency medicine. The company is headquartered in Stockholm, Sweden | Chairman | 01.01.1983 |
Ehemalige bekannte Positionen von Wolfgang Marguerre
| Unternehmen | Position | Ende |
|---|---|---|
Octapharma SAS
 Octapharma SAS Pharmaceuticals: MajorHealth Technology Octapharma SAS manufactures pharmaceutical products. The company was founded on October 9, 1991 and is headquartered in Lingolsheim, France. | President | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | Health Technology |
Octapharma Nordic AB
Octapharma Nordic AB Pharmaceuticals: MajorHealth Technology Octapharma Nordic AB specializes in the production and distribution of plasma derivative. Its products are used for the treatment in coagulation disorders, immune disease and intensive care and emergency medicine. The company is headquartered in Stockholm, Sweden | Health Technology |
Octapharma USA, Inc.
Octapharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Octapharma AG, Octapharma USA, Inc. develops and manufactures medicines for hematology, immunotherapy, and critical care patients. The private company is based in Paramus, NJ. | Health Technology |
Octapharma SAS
Octapharma SAS Pharmaceuticals: MajorHealth Technology Octapharma SAS manufactures pharmaceutical products. The company was founded on October 9, 1991 and is headquartered in Lingolsheim, France. | Health Technology |
Octapharma AB
Octapharma AB Pharmaceuticals: MajorHealth Technology Octapharma AB manufactures and distributes pharmaceutical products. Its products used for treatment in coagulation disorders, immune disease, and intensive care and emergency medicine. The company operates as a subsidiary of Octapharma AG. Octapharma was founded in 1997 and is located in Stockholm, Sweden. | Health Technology |
Octapharma Ltd.
Octapharma Ltd. BiotechnologyHealth Technology Part of Octapharma AG, Octapharma Ltd. is a British company that manufactures human protein products. The private company is based in Manchester, UK. Octapharma was founded in 1983. | Health Technology |
Octapharma Gmbh
Octapharma Gmbh Pharmaceuticals: MajorHealth Technology Octapharma GmbH specializes in the development and manufacture of preparations from human plasma. It focuses on virus-inactivated drugs for the treatment of diseases in the fields of immunology, hemophilia and Iten sivmedizin. The company was founded in 1983 and is headquartered in Langenfeld, Germany. | Health Technology |
